https://www.selleckchem.com/products/dzd9008.html
ertension and preeclampsia and the secondary outcomes are adverse maternal and neonatal outcomes. This trial will provide evidence of whether tailoring treatment of mild to moderate gestational hypertension to the individual haemodynamic profile prevents maternal disease progression. NCT02531490 , registered on 24 August 2015. NCT02531490 , registered on 24 August 2015. May-Hegglin anomaly is an autosomal dominant inherited condition, characterized by thrombocytopenia, giant platelets and Dohle-like bodies. Incidence is unknown and affe
Like
Comment
Share
